Alternatives to FDA regulation of lab tests pepper Senate hearing
By Mark McCarty
Regulatory Editor
Regulatory Editor
A Senate hearing on clinical lab testing and its impact on precision medicine included the usual array of concerns about the potential for FDA regulation of lab-developed tests to impede precision medicine.
